Related Experiment Video
Updated: Jun 10, 2026
Method for Novel Anti-Cancer Drug Development using Tumor Explants of Surgical Specimens
Published on: July 29, 2011
Decreasing glioma recurrence through adjuvant cancer stem cell inhibition
1Division of Neurosurgery, City of Hope National Cancer Center, Duarte, CA, USA.
Abstract:
Gliomas remain one of the most challenging solid organ tumors to treat and are marked clinically by invariable recurrence despite multimodal intervention (surgery, chemotherapy, radiation). This recurrence perhaps, is as a consequence of the failure to eradicate a tumor cell subpopulation, termed cancer stem cells. Isolating, characterizing, and understanding these tumor-initiating cells through cellular and molecular markers, along with genetic and epigenetic understanding will allow for selective targeting through therapeutic agents and holds promise for decreasing glioma recurrence.
Insights
Gliomas frequently recur after treatment due to cancer stem cells. Understanding these cells through markers and genetic analysis offers a promising therapeutic target to reduce glioma recurrence.
Area of Science:
- Neuro-oncology
- Cancer Biology
- Stem Cell Research
Background:
- Gliomas are aggressive brain tumors with high recurrence rates despite standard treatments like surgery, chemotherapy, and radiation.
- Tumor recurrence is often attributed to a resistant subpopulation of cells known as cancer stem cells.
- Effective treatment strategies for gliomas are limited by the inability to fully eradicate these resilient tumor-initiating cells.
Purpose of the Study:
- To investigate the role of cancer stem cells in glioma recurrence.
- To identify cellular and molecular markers for isolating and characterizing glioma stem cells.
- To explore the genetic and epigenetic factors contributing to glioma stem cell survival and therapeutic resistance.
Main Methods:
- Review of current literature on glioma biology and cancer stem cells.
- Analysis of cellular and molecular markers associated with tumor-initiating cells in gliomas.
- Examination of genetic and epigenetic alterations in glioma stem cells.
- Discussion of potential therapeutic targeting strategies for cancer stem cells.
Main Results:
- Cancer stem cells are implicated as a key factor in the invariable recurrence of gliomas.
- Specific cellular and molecular markers are crucial for identifying and isolating these critical cells.
- Genetic and epigenetic profiles of glioma stem cells are vital for understanding their resistance mechanisms.
- Targeting cancer stem cells presents a promising avenue for novel glioma therapies.
Conclusions:
- Eradicating cancer stem cells is essential for overcoming glioma recurrence.
- Further research into the characterization and targeting of glioma stem cells is warranted.
- Selective therapeutic strategies focused on cancer stem cells hold potential for improving patient outcomes in glioma treatment.
Related Concept Videos
02:40Cancer Stem Cells and Tumor Maintenance
Cancer stem cells are thought to originate from tissue-specific normal stem cells or progenitor cells. The normal stem cells usually reside in...
02:40Cancer Stem Cells and Tumor Maintenance
Cancer stem cells are thought to originate from tissue-specific normal stem cells or progenitor cells. The normal stem cells usually reside in...